Literature DB >> 1142504

Experiences with priapism.

P J Moloney, G B Elliott, H W Johnson.   

Abstract

During a 10-year period 11 cases of priapism were treated with a saphenocavernous bypass. Uniformly good functional results were obtained if the procedure was done within 36 hours of the commencement of priapism. Prior aspiration and irrigation appear to lengthen this interval. The formation of temporary cavernovenous communication with the superficial venous system of the penis by aspiration and irrigation with large needles is demonstrated and is postulated as a mechanism by which this method of treatment alone is occasionally successful. Persisting graft patency has been associated with impotence. If erection does not occur within 3 months of the saphenous bypass the shunt should be ligated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1142504     DOI: 10.1016/s0022-5347(17)66946-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Urology-epitomes of progress: extracorporeal corporo-venous shunting for priapism.

Authors:  C L Gates; R G Middleton
Journal:  West J Med       Date:  1979-04

2.  Paediatric priapism--treatment conundrum.

Authors:  Amar Shah; Karan Parashar; Harish Chandran
Journal:  Pediatr Surg Int       Date:  2004-10       Impact factor: 1.827

Review 3.  Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel.

Authors:  Andrea Salonia; Suks Minhas; Paolo Capogrosso; Kostas Dimitropolous; Giorgio Ivan Russo; Tharu Tharakan; Uros Milenkovic; Andrea Cocci; Luca Boeri; Murat Gül; Carlo Bettocchi; Joana Carvalho; Arif Kalkanlı; Giovanni Corona; Georgios Hatzichristodoulou; Hugh T Jones; Ates Kadioglu; Juan Ignacio Martinez-Salamanca; Vaibhav Modgil; Ege Can Serefoglu; Paolo Verze
Journal:  Int J Impot Res       Date:  2022-08-22       Impact factor: 2.408

Review 4.  Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU Sexual and Reproductive Health Guidelines panel.

Authors:  S Minhas; A Salonia; U Milenkovic; A Cocci; R Veeratterapillay; K Dimitropoulos; L Boeri; P Capogrosso; N C Cilesiz; M Gul; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; M I Omar; C Bettocchi; J Carvalho; Y Yuhong; G Corona; H Jones; A Kadioglu; J I Martinez-Salamanca; P Verze; E C Serefoglu
Journal:  Int J Impot Res       Date:  2022-09-23       Impact factor: 2.408

5.  Cavernospongiosum shunt in management of priapism: is it a reliable method?

Authors:  M Srougi; M Borrelli; F T Dénes; G M De Góes
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

Review 6.  Drug-induced priapism. Its aetiology, incidence and treatment.

Authors:  J E Baños; F Bosch; M Farré
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

7.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.